Considerations on methylmercury (MeHg) treatments in in vitro studies
- PMID: 22608940
- PMCID: PMC4919664
- DOI: 10.1016/j.neuro.2012.05.002
Considerations on methylmercury (MeHg) treatments in in vitro studies
References
-
- Burbacher TM, Rodier PM, Weiss B. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol. 1990;12:191–202. - PubMed
-
- Castoldi AF, Onishchenko N, Johansson C, Coccini T, Roda E, Vahter M, et al. Neurodevelopmental toxicity of methylmercury: laboratory animal data and their contribution to human risk assessment. Regul Toxicol Pharmacol. 2008;51:215–29. - PubMed
-
- Choi BH, Lapham LW, Amin-Zaki L, Saleem T. Abnormal neuronal migration, deranged cerebral cortical organization, and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmercury poisoning in utero. J Neuropathol Exp Neurol. 1978;37:719–33. - PubMed
-
- Fujimura M, Usuki F, Sawada M, Takashima A. Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology. 2009;30:1000–7. - PubMed
-
- Lapham LW, Cernichiari E, Cox C, Myers GJ, Baggs RB, Brewer R, et al. An analysis of autopsy brain tissue from infants prenatally exposed to methymercury. Neurotoxicology. 1995;16:689–704. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources